| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3843995 | Actas Urológicas Españolas | 2010 | 6 Pages |
Abstract
The over-expression of the NADPH oxidase is involved in the prostate cancer. Moreover, we suggested that the NADPH oxidase, in combination with other classical markers, could be an indicator for the post-treatment monitoring of the patients diagnosed with hyperplasia and others minors pathologies of the prostate.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
E. Floriano-Sánchez, M. Castro-MarÃn, N. Cárdenas-RodrÃguez, E. Lara-Padilla,